関連する実験動画
Updated: Jan 25, 2026

11:37
In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells
Published on: February 18, 2015
14.2K
適応 的 な 免疫 抵抗 は 腫瘍 を 引き起こす 幹 細胞 から 生じ ます
Yuxuan Miao1, Hanseul Yang1, John Levorse1
1Robin Chemers Neustein Laboratory of Mammalian Cell Biology and Development, Howard Hughes Medical Institute, The Rockefeller University, New York, NY 10065, USA.
Cell
|April 30, 2019
まとめ
腫瘍を誘発する幹細胞 (tSCs) は,T細胞を抑制するCD80を発現することによって,免疫療法に抵抗します. この相互作用を阻害したり,TGF-βを標的にしたりすると,がん免疫療法後の腫瘍の再発が減少します.
科学分野:
- 免疫学
- 腫瘍学
- 幹細胞生物学
背景:
- 免疫系は通常,がん細胞を排除する.
- 腫瘍を誘発する幹細胞 (tSCs) は免疫監視を回避するが,そのメカニズムは不明である.
- TSCの免疫回避を理解することは,効果的ながん免疫療法にとって極めて重要です.
研究 の 目的:
- 腫瘍を誘発する幹細胞 (tSCs) が免疫療法にどのように抵抗するかを調査する.
- 免疫監視を克服するメカニズムを特定する.
- アドプティブ・セル・トランスファー (ACT) 免疫療法の有効性を向上させる戦略を開発する.
主な方法:
- ACT免疫療法のための皮膚状細胞癌 (SCC) モデルを開発した.
- 単細胞RNA配列解析 (RNA-seq) と系統追跡を用いた.
- tSCの免疫回避における変形成長因子β (TGF-β) とCD80の役割を調査した.
主要な成果:
- TGF-β反応型tSCはACTに抵抗し,腫瘍の再発を誘導することが判明した.
- tSCは,CTLA4経由で細胞毒性T細胞活動を抑制するリガンドであるCD80を吸収する.
- CTLA4またはTGF-βを阻害したり,CD80を消去したりすることで,ACTに対するtSCを敏感にし,再発を減少させました.
結論:
- tSCは,抗腫瘍T細胞の反応を積極的に抑制するためにCD80を利用する.
- 免疫チェックポイント経路はtSCによって活性化され,免疫逃避を促進します.
- tSC媒介の免疫抑制をターゲットにすることで,免疫療法の成果を向上させるための有望な戦略が提供されます.
関連する概念動画
Cells of the Adaptive Immune Response
8.5K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
8.5K
Introduction to Innate and Adaptive Immunity
9.1K
The human immune system is a complex defense mechanism that protects the body from harmful pathogens and foreign substances. It comprises two crucial components: innate and adaptive immunity.
Innate immunity is the body's natural, nonspecific defense system that acts quickly to protect against pathogens. It incorporates physical barriers like skin and mucous membranes and cellular elements such as phagocytes and natural killer cells. This part of our immune system provides an immediate,...
Innate immunity is the body's natural, nonspecific defense system that acts quickly to protect against pathogens. It incorporates physical barriers like skin and mucous membranes and cellular elements such as phagocytes and natural killer cells. This part of our immune system provides an immediate,...
9.1K
Special Features of Adaptive Immunity
3.0K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
3.0K
Antigens Involved in Adaptive Immunity
1.3K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.3K
What is the Immune System?
127.2K
Overview
127.2K
Cancer Stem Cells and Tumor Maintenance
5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K

